Jim Simons
ALLR

Jim Simons’s Allarity Therapeutics ALLR Stock Holding History

Jim Simons’s Portfolio ALLR Stock Details ALLR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$249K Sell
228,084
-19,528
-8% -$21K ﹤0.01% 2863
2025
Q4 		$267K Buy
247,612
+181,426
+274% +$231K ﹤0.01% 2802
2025
Q3 		$105K Buy
+66,186
New +$83.1K ﹤0.01% 3242
2023
Q1 		– Hold
0
– -$11K – 3939
2022
Q4 		– Hold
0
– – – 4028
2022
Q3 		– Hold
0
– – – 3853
2022
Q2 		– Hold
0
– – – 3813
2022
Q1 		– Hold
0
– – – 3586

Other funds holding ALLR

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Jim Simons's ALLR Position: Q1 2026 in Review

Jim Simons reduced its Allarity Therapeutics (ALLR) stake by 7.9% in Q1 2026, selling an estimated $21K and leaving 228,084 shares worth $249K. The position accounts for ﹤0.01% of the portfolio, ranked #2863.

Jim Simons first reported a position in ALLR in Q3 2025 and has held it in 3 quarters since. The position peaked at $267K in Q4 2025. 14 funds tracked by Wall St. Rank hold ALLR as of Q1 2026.

  • Jim Simons held 228,084 shares of Allarity Therapeutics worth $249K as of Q1 2026.
  • Jim Simons sold 19,528 Allarity Therapeutics shares in Q1 2026, an estimated $21K.
  • Allarity Therapeutics made up ﹤0.01% of Jim Simons's portfolio in Q1 2026, its #2863 holding.
  • Jim Simons first reported a position in Allarity Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • Jim Simons's Allarity Therapeutics position peaked at $267K in Q4 2025.
  • 14 funds tracked by Wall St. Rank held Allarity Therapeutics as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.